Histone profiling reveals the H1.3 histone variant as a prognostic biomarker for pancreatic ductal adenocarcinoma

MLA

Monika Bauden, et al. “Histone Profiling Reveals the H1.3 Histone Variant as a Prognostic Biomarker for Pancreatic Ductal Adenocarcinoma.” BMC Cancer, vol. 17, no. 1, Dec. 2017, pp. 1–9. EBSCOhost, https://doi.org/10.1186/s12885-017-3834-z.

APA

Monika Bauden, Theresa Kristl, Agata Sasor, Bodil Andersson, György Marko-Varga, Roland Andersson, & Daniel Ansari. (2017). Histone profiling reveals the H1.3 histone variant as a prognostic biomarker for pancreatic ductal adenocarcinoma. BMC Cancer, 17(1), 1–9. https://doi.org/10.1186/s12885-017-3834-z

Chicago

Monika Bauden, Theresa Kristl, Agata Sasor, Bodil Andersson, György Marko-Varga, Roland Andersson, and Daniel Ansari. 2017. “Histone Profiling Reveals the H1.3 Histone Variant as a Prognostic Biomarker for Pancreatic Ductal Adenocarcinoma.” BMC Cancer 17 (1): 1–9. doi:10.1186/s12885-017-3834-z.